DR. HEATHER YECKES-RODIN M.D. NPI 1740214840

NPI Details

DR. Heather Yeckes-rodin, M.D. is a hematology and oncology internal medicine in Port St. Lucie, FL with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Heather Yeckes-rodin, M.D. NPI is 1740214840. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

1871 S. E. TIFFANY AVE
SUITE 100
PORT ST. LUCIE, FL
ZIP 34952-596
Phone: (772) 355-5666
Fax: (772) 335-3781

The NPI 1740214840 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Ferritin (blood protein) level (HCPCS:82728)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Folic acid level, serum (HCPCS:82746)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of chest without contrast (HCPCS:71250)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Magnesium level (HCPCS:83735)
• Ct scan of chest with contrast (HCPCS:71260)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Blood test, clotting time (HCPCS:85610)
• Anticoagulant management of patient taking warfarin (HCPCS:93793)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)
• Drawing of blood for a medical problem (HCPCS:99195)
• Ct scan of soft tissue of neck without contrast (HCPCS:70490)
• Stool analysis for blood, by peroxidase activity (HCPCS:82272)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Collection of blood sample from implanted device (HCPCS:36591)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, lorazepam, 2 mg (HCPCS:J2060)

The enumeration date for this NPI number is 7/11/2006 and was last updated on 10/9/2009.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.